The Journal of Immunology, Vol 156, Issue 12 4821-4832, Copyright © 1996 by American Association of Immunologists

ARTICLES

Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component

JD Lambris, Z Lao, TJ Oglesby, JP Atkinson, CE Hack and JD Becherer
Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104-6079, USA.

Previous studies have suggested that the residues 727-768 of human (Hu) C3 contain the binding sites for CR1, factor H, and factor B. Here, we have (1) characterized further some of the C3 structural requirements for its binding to CR1, H, and B, (2) investigated the functions associated with these C3-ligand interactions, and (3) studied the relationship of MCP-binding sites in C3 with those for CR1, H, and B. Hu C3 molecules in which residues 727-768 were deleted (designated C3delta727-768) or substituted with the corresponding segment of cobra venom factor, Xenopus, or trout C3 (chimeric C3s) were expressed in the baculovirus system and analyzed for their reactivity with C3-binding proteins. In contrast to wild-type iC3 which, in the presence of CR1, is cleaved by factor I to iC3b-a and C3c-a and C3dg, all chimeric C3s were cleaved only to iC3b-a. In addition, the cleavage of deleted (C3delta727-768) iC3 to iC3b-a by factor I in the presence of CR1 was significantly reduced, whereas it remained unaltered in the presence of MCP. Cleavage of iC3 to iC3b-a by factor I and H was similar in all expressed C3s except C3delta727-768, whose cleavage was significantly reduced. All of the expressed molecules except C3delta727-768 were capable of forming the fluid-phase alternative pathway C3 convertase, and all reacted with properdin. These results suggest that during cleavage of iC3 by factor I and CR1, or H, CR1 and H bind to at least two sites on C3 and that the MCP binding site(s) on C3b are different from those for CR1. They also indicate that some or all of the C3 residues that are directly involved in, or contribute to, the structure of one of the CR1 and H binding sites are located within residues 727- 768. These studies also demonstrate that, although this segment of C3 may be involved in C3-factor B interaction, other residues in addition to 736EE (previously implicated in B binding) must also contribute significantly to this interaction.

This article has been cited by other articles:

				Z. Banki, D. Wilflingseder, C. G. Ammann, M. Pruenster, B. Mullauer, K. Hollander, M. Meyer, G. M. Sprinzl, J. van Lunzen, H.-J. Stellbrink, et al. Factor I-Mediated Processing of Complement Fragments on HIV Immune Complexes Targets HIV to CR2-Expressing B Cells and Facilitates B Cell-Mediated Transmission of Opsonized HIV to T Cells. J. Immunol., September 1, 2006; 177(5): 3469 - 3476. [Abstract] [Full Text] [PDF]

				M. S. Winters, D. S. Spellman, and J. D. Lambris Solvent Accessibility of Native and Hydrolyzed Human Complement Protein 3 Analyzed by Hydrogen/Deuterium Exchange and Mass Spectrometry J. Immunol., March 15, 2005; 174(6): 3469 - 3474. [Abstract] [Full Text] [PDF]

				C. L. Harris, R. J. M. Abbott, R. A. Smith, B. P. Morgan, and S. M. Lea Molecular Dissection of Interactions between Components of the Alternative Pathway of Complement and Decay Accelerating Factor (CD55) J. Biol. Chem., January 28, 2005; 280(4): 2569 - 2578. [Abstract] [Full Text] [PDF]

				J. Kolln, E. Spillner, J. Andra, K. Klensang, and R. Bredehorst Complement Inactivation by Recombinant Human C3 Derivatives J. Immunol., November 1, 2004; 173(9): 5540 - 5545. [Abstract] [Full Text] [PDF]

				V Fremeaux-Bacchi, M-A Dragon-Durey, J Blouin, C Vigneau, D Kuypers, B Boudailliez, C Loirat, E Rondeau, and W H Fridman Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome J. Med. Genet., June 1, 2004; 41(6): e84 - e84. [Full Text] [PDF]

				C.-T. Thai and R. T. Ogata Expression and Characterization of the C345C/NTR Domains of Complement Components C3 and C5 J. Immunol., December 15, 2003; 171(12): 6565 - 6573. [Abstract] [Full Text] [PDF]

				J. Hellwage, T. S. Jokiranta, M. A. Friese, T. U. Wolk, E. Kampen, P. F. Zipfel, and S. Meri Complement C3b/C3d and Cell Surface Polyanions Are Recognized by Overlapping Binding Sites on the Most Carboxyl-Terminal Domain of Complement Factor H J. Immunol., December 15, 2002; 169(12): 6935 - 6944. [Abstract] [Full Text] [PDF]

				J. M. Inal and J. A. Schifferli Complement C2 Receptor Inhibitor Trispanning and the {beta}-Chain of C4 Share a Binding Site for Complement C2 J. Immunol., May 15, 2002; 168(10): 5213 - 5221. [Abstract] [Full Text] [PDF]

				Q. Pan, R. O. Ebanks, and D. E. Isenman Two Clusters of Acidic Amino Acids Near the NH2 Terminus of Complement Component C4 {alpha}'-Chain Are Important for C2 Binding J. Immunol., September 1, 2000; 165(5): 2518 - 2527. [Abstract] [Full Text] [PDF]

				A. E. Oran and D. E. Isenman Identification of Residues within the 727-767 Segment of Human Complement Component C3 Important for Its Interaction with Factor H and with Complement Receptor 1 (CR1, CD35) J. Biol. Chem., February 19, 1999; 274(8): 5120 - 5130. [Abstract] [Full Text] [PDF]

				R. T. Ogata, R. Ai, and P. J. Low Active Sites in Complement Component C3 Mapped by Mutations at Indels J. Immunol., November 1, 1998; 161(9): 4785 - 4794. [Abstract] [Full Text] [PDF]

				R. Ameratunga, J. A. Winkelstein, L. Brody, M. Binns, L. C. Cork, P. Colombani, and D. Valle Molecular Analysis of the Third Component of Canine Complement (C3) and Identification of the Mutation Responsible for Hereditary Canine C3 Deficiency J. Immunol., March 15, 1998; 160(6): 2824 - 2830. [Abstract] [Full Text] [PDF]

				T. S. Jokiranta, J. Hellwage, V. Koistinen, P. F. Zipfel, and S. Meri Each of the Three Binding Sites on Complement Factor H Interacts with a Distinct Site on C3b J. Biol. Chem., September 1, 2000; 275(36): 27657 - 27662. [Abstract] [Full Text] [PDF]

				M. K. Liszewski, M. Leung, W. Cui, V. B. Subramanian, J. Parkinson, P. N. Barlow, M. Manchester, and J. P. Atkinson Dissecting Sites Important for Complement Regulatory Activity in Membrane Cofactor Protein (MCP; CD46) J. Biol. Chem., November 22, 2000; 275(48): 37692 - 37701. [Abstract] [Full Text] [PDF]